Nurturing the stem cell business: lessons from the recombinant drugs markets?

ISSN： 0963-6048

Source： International Journal of Biotechnology, Vol.8, Iss.3-4, 2006-03, pp. : 187-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commercialisation of bio-pharmaceutical therapies and risk management: the impact on the sustainability of markets for recombinant drugs

By Wink Rudiger

International Journal of Biotechnology, Vol. 6, Iss. 2-3, 2004-07 ,pp. : 186-201

Inderscience Publishers

Access to resources Recommend Favorite

Expression, Renaturation and Simultaneous Purification of Recombinant Human Stem Cell Factor in Escherichia coli

By Lili Wang Chaozhan Wang Xindu Geng

Biotechnology Letters, Vol. 28, Iss. 13, 2006-07 ,pp. : 993-997

Springer Publishing Company

Access to resources Recommend Favorite

Centrifugal processing of cell debris and inclusion bodies from recombinant Escherichia coli

By Wong H.H. O'neill B.K. Middelberg A.P.J.

Bioseparation, Vol. 6, Iss. 6, 1996-01 ,pp. : 361-372

Springer Publishing Company

Access to resources Recommend Favorite

Blazing the trail from stem cell research to regenerative medicine

By Bower D. Jane Murad A. Najib Sulej Julian C. Tait Joyce

International Journal of Biotechnology, Vol. 10, Iss. 5, 2008-11 ,pp. : 461-475

Inderscience Publishers

Access to resources Recommend Favorite

Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood

Journal Of Tissue Engineering And Regenerative Medicine, Vol. 1932-6254, Iss. 9, 2015-09 ,pp. : 988-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite